9.25
Artelo Biosciences Inc Azioni (ARTL) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
|
37.59%
2.379
|
3.812 | 1.195 | 2.512 | 2.589 |
Operating Income/Loss |
37.59%
-2.379
|
-3.812 | -1.195 | -2.512 | -2.589 |
Nonoperating Income/Loss |
79.41%
0.007
|
0.034 | 0.063 | 0.079 | 0.106 |
Income/Loss From Continuing Operations Before Tax |
85.06%
-2.372
|
-15.87 | -1.132 | -2.433 | -2.483 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
85.06%
-2.372
|
-15.87 | -1.132 | -2.433 | -2.483 |
|
85.06%
-2.372
|
-15.87 | -1.132 | -2.433 | -2.483 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
100.00%
-
|
-12.10 | - | - | - |
Diluted Average Shares |
32,710%
3.281
|
0.01 | 3.228 | - | - |
Diluted Earnings Per Share |
38.46%
-0.72
|
-1.17 | -0.35 | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):